JOSE FRANCO REYES: Open Payments
NPI 1396812954 · MAGNOLIA, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,112 in 59 payments from 8 companies in 2025. Trend: 2023 $1,091 · 2024 $1,120 · 2025 $1,112
Food & beverage: $1,000Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 11 | $270 |
| E.R. Squibb & Sons, L.L.C. | 13 | $215 |
| Alkermes, Inc. | 13 | $209 |
| Neurocrine BioSciences, Inc. | 8 | $162 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $91 |
| ABBVIE INC. | 4 | $66 |
| Janssen Pharmaceuticals, Inc | 3 | $62 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
Products named: COBENFY, ARISTADA, INGREZZA, CAPLYTA, AUSTEDO XR, UZEDY, VRAYLAR, INVEGA.
Industry payments across NJ — which companies pay providers there.
